Prev Arrow Stocks

Humana Inc. ($HUM) Stock Forecast: Up 5.5% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Humana Inc.?

Humana Inc. (NYSE: HUM) is a leading health insurance company with a market capitalization of $30.99 billion. The company offers a range of healthcare services and insurance products, including Medicare plans.

Why is Humana Inc. going up?

HUM stock is up 5.5% on Feb 12, 2025 16:01

  • Despite facing a wider year-over-year loss in Q4 due to a decline in membership, Humana's stock showed strong bullish movement recently.
  • The positive market response can likely be linked to Humana's impressive 13% revenue growth in Q4, exceeding expectations and demonstrating the company's strength in a challenging business landscape.
  • Furthermore, Humana's stock has outperformed the market by 2.35% annually over the past two decades, potentially boosting investor confidence and driving the current bullish trend.
  • The ongoing lawsuit concerning specific investors in Humana shares seems to have had minimal impact on the stock's performance, with market attention mainly focusing on the company's financial results and future growth prospects.

HUM Price Chart

HUM Technical Analysis

HUM News

Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years - Humana ( NYSE:HUM )

Humana HUM has outperformed the market over the past 20 years by 2.35% on an annualized basis producing an average annual return of 10.76%. Currently, Humana has a market capitalization of $30.99 billion.

https://www.benzinga.com/insights/news/25/02/43644518/heres-how-much-you-would-have-made-owning-humana-stock-in-the-last-20-years

0 News Article Image Here's How Much You Would Have Made Owning Humana Stock In The Last 20 Years - Humana  ( NYSE:HUM )

Humana Incurs Wider Y/Y Loss in Q4 on Decline in Membership

HUM's fourth-quarter results suffer a blow due to a membership decline in Medicare stand-alone PDP, partly offset by a strong Primary Care business. It currently expects 2025 adjusted EPS to be around $16.25.

https://www.zacks.com/stock/news/2413988/humana-incurs-wider-yy-loss-in-q4-on-decline-in-membership

1 Missing News Article Image Humana Incurs Wider Y/Y Loss in Q4 on Decline in Membership

NYSE: HUM Lawsuit Update: Investors who lost money with Humana Inc. ( NYSE: HUM ) shares should contact the Shareholders Foundation - Humana ( NYSE:HUM )

SAN DIEGO, Feb. 11, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of Humana Inc. HUM. Investors who purchased shares of Humana Inc.

https://www.benzinga.com/pressreleases/25/02/n43627786/nyse-hum-lawsuit-update-investors-who-lost-money-with-humana-inc-nyse-hum-shares-should-contact-th

2 News Article Image NYSE: HUM Lawsuit Update: Investors who lost money with Humana Inc.  ( NYSE: HUM )  shares should contact the Shareholders Foundation - Humana  ( NYSE:HUM )

Insurance Giant Humana's Q4 Earnings: 13% Revenue Growth, 2025 Profit Outlook Falls Below Street View - Humana ( NYSE:HUM )

Humana posted Q4 adjusted EPS loss of $2.16, in line with estimates, with revenue of $29.19B, beating the $28.84B consensus. The company expects 2025 GAAP sales of $126B-$128B, with individual Medicare Advantage membership projected to decline by 550K, or 10%.

https://www.benzinga.com/25/02/43621782/insurance-giant-humanas-q4-earnings-at-par-with-estimates-2025-profit-outlook-falls-below-street-view

3 News Article Image Insurance Giant Humana's Q4 Earnings: 13% Revenue Growth, 2025 Profit Outlook Falls Below Street View - Humana  ( NYSE:HUM )

Humana ( HUM ) Reports Q4 Loss, Tops Revenue Estimates

Humana (HUM) delivered earnings and revenue surprises of 4.42% and 1.05%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2413368/humana-hum-reports-q4-loss-tops-revenue-estimates

4 Missing News Article Image Humana  ( HUM )  Reports Q4 Loss, Tops Revenue Estimates

Humana Inc. Price History

06.10.2024 - HUM Stock was up 7.6%

  • Humana's strong bullish movement today can be attributed to its better-than-expected Q3 earnings results, driven by growing premiums and effective cost management strategies.
  • The increase in Medicare Advantage membership has positively impacted Humana's financial performance, reflecting strong demand for its insurance products.
  • The market likely reacted favorably to Humana's ability to effectively manage costs while expanding its customer base, signaling a healthy and profitable business outlook for the company in the healthcare insurance sector.

20.11.2024 - HUM Stock was up 5.7%

  • The bullish movement in HUM's stock could be attributed to positive company developments that have boosted investor confidence in the company's future prospects.
  • The increase in bullish options trading on HUM suggests that smart money investors are optimistic about the stock's performance in the near future, potentially indicating expectations of strong financial results or strategic initiatives.
  • Overall, the combination of positive company developments and bullish options activity may have contributed to the strong upward movement in HUM's stock price today, signaling a positive sentiment among investors towards the company.

06.10.2024 - HUM Stock was up 11.2%

  • Even though some investors took a bearish stance through options trading, Humana's stock experienced significant bullish movement today.
  • The divergence between options trading trends and the stock's actual performance may suggest a disconnect between investor sentiment and the company's market movements.
  • Positive developments like strong financial results or strategic partnerships within Humana could be driving the stock price up, outweighing the bearish sentiment seen in options trading.
  • It is advisable for investors to keep a close eye on both market indicators and company-specific updates to make well-informed decisions regarding trading on Humana.

21.09.2024 - HUM Stock was down 5.1%

  • The reinitiation of merger talks with Cigna Group might have caused uncertainty and concerns among investors, leading to a bearish sentiment towards Humana's stock.
  • The ongoing investigation by Bronstein, Gewirtz & Grossman, LLC could have raised red flags for investors, impacting the stock's performance negatively.
  • The bullish stance taken by market whales on Humana's options might not have been enough to counteract the overall bearish market sentiment surrounding the stock today.

02.09.2024 - HUM Stock was down 12.2%

  • The bearish movement in Humana's stock today is attributed to a sharp decline in its Medicare Star Ratings for 2025. This could raise concerns about the company's future revenue prospects.
  • Options trading sentiment shows that a majority of investors have a bearish stance on Humana, contributing to the stock's downward pressure.
  • Despite the negative market movement, Humana has historically outperformed the market over the past 15 years, demonstrating its resilience and long-term growth potential.
  • The overall market sentiment, including big stocks like Nike (NYSE: NKE) moving lower in the pre-market session, might have influenced the bearish trend in Humana's stock as investors approached healthcare and consumer goods companies cautiously.

03.09.2024 - HUM Stock was up 5.3%

  • Despite a decline in its Medicare Star Ratings for 2025, Humana's stock displayed a strong bullish movement today.
  • Ongoing investigations into potential securities law violations did not seem to impact investor sentiment, reflecting confidence in the company's foundation.
  • Technical analysis pointing towards a possible future rally may have encouraged optimism among traders, leading to increased buying activity.
  • Despite some investors taking a bearish stance in options trading, there was no ensuing downward trend, highlighting the stock's resilience in the face of market uncertainties.

08.09.2024 - HUM Stock was up 5.3%

  • Humana's stock price has neared its 52-week lows, potentially attractive for investors looking to buy.
  • Despite hurdles like member decline and increased costs, investors, including well-funded ones, have shown optimism, as seen through recent options trading.
  • An inquiry launched into Humana's activities after a notable stock price drop may have caused uncertainty. Nevertheless, investor positivity centers around the perceived chance to buy at lower prices.
  • The notable bullish activity in Humana's stock today may be linked to the combined factors of potential buying opportunities, optimistic options trading, and ongoing investigations.

12.01.2025 - HUM Stock was up 5.5%

  • Despite facing a wider year-over-year loss in Q4 due to a decline in membership, Humana's stock showed strong bullish movement recently.
  • The positive market response can likely be linked to Humana's impressive 13% revenue growth in Q4, exceeding expectations and demonstrating the company's strength in a challenging business landscape.
  • Furthermore, Humana's stock has outperformed the market by 2.35% annually over the past two decades, potentially boosting investor confidence and driving the current bullish trend.
  • The ongoing lawsuit concerning specific investors in Humana shares seems to have had minimal impact on the stock's performance, with market attention mainly focusing on the company's financial results and future growth prospects.

17.11.2024 - HUM Stock was down 11.5%

  • Smart money investors have taken a bearish stance on Humana by betting big on HUM options.
  • This significant bearish movement could be attributed to the actions of institutional investors or wealthy individuals who are making large bets against the stock.
  • The increased bearish sentiment in the options market may indicate a negative outlook on Humana's future performance, leading to the strong bearish movement in the stock price today.

23.00.2025 - HUM Stock was up 7.5%

  • Humana's impressive earnings surprise history and positive outlook for its next quarterly report are driving investor confidence and contributing to the bullish movement.
  • The drop in shares of insurance and pharmacy benefit manager companies following disappointing revenue results from another company is putting pressure on the sector, but Humana seems to be holding up well.
  • Despite concerns about potential impacts from the earnings report of another company, Humana's strong fundamentals, including improved premiums, contract wins, and collaborations, are likely reassuring investors and supporting the bullish trend.
  • Overall, while market conditions and sector performance are affecting Humana's stock price, the company's growth prospects and strategic initiatives are positioning it favorably for continued success.

11.01.2025 - HUM Stock was down 9.0%

  • Humana reported a wider year-over-year loss in Q4, primarily due to a decline in membership in Medicare stand-alone PDP, which impacted its financial performance negatively.
  • The company's 2025 profit outlook fell below street expectations, with a projected decline in individual Medicare Advantage membership for the year.
  • The pending lawsuit update may have also contributed to investor concerns and added pressure on the stock price.
  • Overall, the combination of poor financial results, lower profit outlook, and legal uncertainties likely led to the bearish movement in Humana's stock today.

11.01.2025 - HUM Stock was down 4.1%

  • Humana's Q4 earnings report showed a 13% revenue growth but with a profit outlook for 2025 falling below street expectations, leading to investor concerns and a bearish market movement.
  • The lawsuit update for certain investors in Humana Inc. shares might have added to the negative sentiment surrounding the stock.
  • Escalating operating costs and the projected decline in individual Medicare Advantage membership could have contributed to the disappointing outlook, impacting the stock's performance.
  • The combination of lower-than-expected profit outlook, ongoing legal issues, and concerns about future growth prospects likely fueled the bearish movement in Humana's stock today.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.